The US recognizes the positive results of the efforts of The Dominican Republic. The Dominican Republic actions include more effective regulatory protection against pharmaceutical patent infringement by the authorities, and protection of undisclosed test and other data generated to obtain marketing approval for pharmaceutical products against unfair commercial use and unauthorized disclosure, a trademark database available online. Though, serious concerns remain – a need of coordination between enforcement agencies, need to effectively address signal theft, the long patent terms and pending patent applications, and not least the free distribution of pirated and counterfeit goods.
The entire report can be found here.
